Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Limited common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive (loss)
Beginning balance (in shares) at Dec. 31, 2021		61,834,515	9,164,193
Beginning balance at Dec. 31, 2021	$ 557,071	$ 618	$ 92	$ 786,964	$ (229,952)	$ (651)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	(2,006)					(2,006)
Issuances of common stock upon stock option exercises (in shares)		137,885
Issuances of common stock upon stock option exercises	908	$ 2		906
Stock-based compensation	9,134			9,134
Net income (loss)	(34,440)				(34,440)
Ending balance (in shares) at Mar. 31, 2022		61,972,400	9,164,193
Ending balance at Mar. 31, 2022	530,667	$ 620	$ 92	797,004	(264,392)	(2,657)
Beginning balance (in shares) at Dec. 31, 2021		61,834,515	9,164,193
Beginning balance at Dec. 31, 2021	557,071	$ 618	$ 92	786,964	(229,952)	(651)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	(2,752)
Net income (loss)	(82,126)
Ending balance (in shares) at Jun. 30, 2022		62,027,061	9,164,193
Ending balance at Jun. 30, 2022	493,058	$ 620	$ 92	807,827	(312,078)	(3,403)
Beginning balance (in shares) at Mar. 31, 2022		61,972,400	9,164,193
Beginning balance at Mar. 31, 2022	530,667	$ 620	$ 92	797,004	(264,392)	(2,657)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	(746)					(746)
Issuances of common stock upon stock option exercises (in shares)		54,661
Issuances of common stock upon stock option exercises	396			396
Stock-based compensation	10,427			10,427
Net income (loss)	(47,686)				(47,686)
Ending balance (in shares) at Jun. 30, 2022		62,027,061	9,164,193
Ending balance at Jun. 30, 2022	493,058	$ 620	$ 92	807,827	(312,078)	(3,403)
Beginning balance (in shares) at Dec. 31, 2022		62,163,739	9,164,193
Beginning balance at Dec. 31, 2022	447,894	$ 622	$ 92	828,700	(379,138)	(2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	1,483					1,483
Issuances of common stock upon stock option exercises (in shares)		186,201
Issuances of common stock upon stock option exercises	867	$ 1		866
Issuance of common stock upon vesting of restricted stock units (in shares)		12,075
Stock-based compensation	10,880			10,880
Net income (loss)	129,136				129,136
Ending balance (in shares) at Mar. 31, 2023		62,362,015	9,164,193
Ending balance at Mar. 31, 2023	590,260	$ 623	$ 92	840,446	(250,002)	(899)
Beginning balance (in shares) at Dec. 31, 2022		62,163,739	9,164,193
Beginning balance at Dec. 31, 2022	447,894	$ 622	$ 92	828,700	(379,138)	(2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	1,699
Net income (loss)	133,414
Ending balance (in shares) at Jun. 30, 2023		62,702,244	9,164,193
Ending balance at Jun. 30, 2023	611,225	$ 627	$ 92	856,913	(245,724)	(683)
Beginning balance (in shares) at Mar. 31, 2023		62,362,015	9,164,193
Beginning balance at Mar. 31, 2023	590,260	$ 623	$ 92	840,446	(250,002)	(899)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized gain (loss) on marketable securities	216					216
Issuances of common stock upon stock option exercises (in shares)		340,229
Issuances of common stock upon stock option exercises	4,698	$ 4		4,694
Stock-based compensation	11,773			11,773
Net income (loss)	4,278				4,278
Ending balance (in shares) at Jun. 30, 2023		62,702,244	9,164,193
Ending balance at Jun. 30, 2023	$ 611,225	$ 627	$ 92	$ 856,913	$ (245,724)	$ (683)